Bortezomib In Combination with Rituximab, Cyclophosphamide, and Prednisone with or without Doxorubicin Followed by Rituximab Maintenance In Patients with Relapsed or Refractory Follicular Lymphoma: Results of a Phase 2 Study

被引：0

作者：

Craig, Michael ^{[1
]}

Hanna, Wahid T. ^{[2
]}

Cabanillas, Fernando ^{[3
]}

Chen, Chien-Shing ^{[4
]}

Parasuraman, Sudha ^{[5
]}

Neuwirth, Rachel ^{[5
]}

O'Connor, Owen A. ^{[6
]}

机构：

[1] W Virginia Univ, Mary Babb Randolph Canc Ctr, Robert C Byrd Hlth Sci Ctr, Morgantown, WV 26506 USA

[2] Univ Tennessee, Inst Canc, Knoxville, TN USA

[3] Auxilio Mutuo Canc Ctr, San Juan, PR USA

[4] Loma Linda Univ, Ctr Canc, Div Hematol Oncol, Loma Linda, CA 92350 USA

[5] Millennium Pharmaceut Inc, Cambridge, MA USA

[6] NYU Langone Med Ctr, NYU Clin Canc Inst, New York, NY USA

来源：

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1153 / 1154

页数：2